-2%
Viltica Inhalation Capsule
- Long-term, once-daily maintenance treatment for airflow obstruction and reducing exacerbations in chronic obstructive pulmonary disease (COPD) patients.
- Once-daily treatment of asthma in adults (18 years and older).
- Important Limitation: Not for relief of acute bronchospasm.
- রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Vilanterol Trifenatate is a long-acting beta-2 agonist for treating asthma and diffuse airway obstruction. Fluticasone Furoate, a corticosteroid, provides anti-inflammatory effects, targeting symptoms of asthma and COPD
Asthma
Asthma is a chronic respiratory condition marked by the narrowing and inflammation of the bronchial airways, which results in difficulty breathing. Common symptoms include chest tightness, wheezing (a whistling sound while breathing), shortness of breath, and nighttime coughing. Asthma management typically involves medications, breathing exercises, and lifestyle adjustments to reduce symptom frequency and severity.
Chronic Obstructive Pulmonary Disease (COPD)
COPD is an umbrella term for a group of progressive lung diseases, primarily emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tubes). Symptoms often include chronic coughing, shortness of breath, and wheezing. Common causes include smoking and prolonged exposure to pollutants, fumes, and chemicals. Treatments focus on medication, lifestyle changes, and respiratory therapy to ease symptoms and improve quality of life.